Endocrinology

Host: Carol Wysham

Guest: Alexis McKee, MD

Patient care has evolved amid the COVID-19 pandemic, causing unexpected challenges in managing diseases such as diabetes. Dr. Carol Wysham joins Dr. Alexis McKee, a practicing endocrinologist and an assistant professor of medicine at Washington School of Medicine in St. Louis, Missouri, to discuss how patients have been overcoming challenges in managing diabetes during the pandemic.

Host: John Buse, MD, PhD

Guest: David Wheeler, MB, CHB, MD, FRCP

Recent research has revealed that a type 2 diabetes treatment may help manage chronic kidney disease. Dr. John Buse discusses the use of dapagliflozin in patients with chronic kidney disease with Dr. David Wheeler, a professor of kidney medicine at the University College London in the United Kingdom, and an honorary consultant nephrologist at the Royal Free London NHS Foundation Trust.

Host: Carol Wysham

Guest: Janet B. McGill, MD, MA, FACE, FACP

Many patients with diabetes don’t fit into our stereotypes of type 1 or type 2 diabetes and identifying them is key to understanding how to treat them. Dr. Carol Wysham discusses atypical diabetes with Dr. Janet McGill, a professor of medicine at the Washington School of Medicine in St. Louis, Missouri.

Host: Matthew J. Sorrentino, MD, FACC, FASH

Guest: Alan S. Brown, MD, FACC, FAHA, FNLA

With an explosion in new medications to treat diabetes, Heart Matters hosts Dr. Matthew Sorrentino and Dr. Alan Brown sit down to discuss the cardiovascular risk benefits of these new diabetes treatments and how cardiologists can improve patient care.

Host: John E. Anderson, MD

Guest: Jason Sloane, MD

There’s no denying that the COVID-19 pandemic has impacted every aspect of healthcare. So in an effort to recognize those who’ve gone above and beyond the call of duty, ReachMD’s Heroes in Healthcare initiative honors those healthcare professionals who were nominated by their peers for their outstanding contributions to the field of medicine. And one such nominee, Dr. Jason Sloane, joins Dr. John Anderson to discuss this nomination, strategies for optimal care, and his response to the COVID-19 pandemic.

Host: John E. Anderson, MD

Host: John Buse, MD, PhD

Host: Carol Wysham

The guidelines for healthy eating encourage a balance of many things, but doesn’t address the specific amount of carbohydrates, protein, and fat. And with so many fad diets circulating, how do we develop informed dietary recommendations for our patients with type 2 diabetes? Dr. Kathleen Stanley, a registered dietitian and certified diabetes educator with the Baptist Health Center discusses factors to take into consideration when making these decisions.

Host: Shira Johnson, MD

Guest: Sabrina E. Noel, PhD, RD

While osteoporosis was thought to have affected primarily non-Hispanic white women, recent evidence suggests that Hispanic men and women have a similar or higher frequency of this chronic condition. Dr. Sabrina E. Noel, Ph.D., R.D., discusses her studies regarding the prevalence of osteoporosis in the Hispanic community.

Host: Shira Johnson, MD

Guest: Andrea J. Singer, MD, FACP, CCD

While osteoporosis-related bone fractures affect nearly 54 million adults in the U.S., there’s a lot we don’t know about this bone disease. With that in mind, Dr. Andrea Singer joins us today to review a recent report from the National Osteoporosis Foundation and discuss the impact of osteoporosis on economic drivers, patient quality of life, and the healthcare system as a whole.

Guest: Lauren K. Brooks, MD

During this unprecedented time, finding the best approach to providing treatment for patients with thyroid cancer can be a challenge. Endocrinologist Dr. Lauren Brooks of Penn Medicine Lancaster General Health shares some of her approaches to this dilemma and stresses the importance of keeping up on routine practices during the COVID-19 pandemic.

Published September 28, 2020

Host: Paul Doghramji, MD

Guest: Maria Escolar, MD, MS

Adrenoleukodystrophy (ALD) is a rare genetic disorder that when left untreated, can have severe and even fatal consequences. Here to review the available treatment options for these patients is Dr. Maria Escolar, the Director of the Program for the Study of Neurodevelopment in Rare Disorders and a Professor of Pediatrics at the University of Pittsburgh School of Medicine.